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Carotid Arterial Remodeling
A Maladaptive Phenomenon in Type 2 Diabetes but Not in Impaired
Glucose Metabolism: The Hoorn Study
Ronald M.A. Henry, MD; Piet J. Kostense, PhD; Jacqueline M. Dekker, PhD; Giel Nijpels, MD, PhD;
Robert J. Heine, MD, PhD; Otto Kamp, MD, PhD; Lex M. Bouter, PhD; Coen D.A. Stehouwer, MD, PhD
Background and Purpose—Deteriorating glucose tolerance is associated with an increased cardiovascular disease (CVD)
risk. The underlying mechanisms remain unclear. Arterial remodeling is the change in structural properties through time
in response to atherogenic and/or hemodynamic alterations and aims to maintain circumferential wall stress constant
(C). Arterial remodeling has not been studied in relation to glucose tolerance.
Methods—The study population consisted of 278 people with normal glucose metabolism, 168 with impaired glucose
metabolism, and 301 with type 2 diabetes (DM-2); their mean age was 67.8 years. We assessed carotid intima-media
thickness (IMT), interadventitial diameter (IAD), lumen diameter (LD), and C.
Results—After adjustment for age, sex, height, body mass index, and prior CVD, DM-2 was associated with increased
IAD, IMT, and C but not LD (regression coefficients: 0.24 mm; 95% confidence interval [CI], 0.07 to 0.41; 0.050 mm;
95% CI, 0.024 to 0.077; 5.00 kPa; 95% CI, 0.92 to 9.08; and 0.13 mm; 95% CI, 0.03 to 0.29, respectively). After
additional adjustment for pulse pressure, the association between DM-2 and IAD disappeared, whereas the association
with IMT remained. After adjustment, impaired glucose metabolism was not significantly associated with LD (0.12 mm;
95% CI, 0.06 to 0.33), C (0.25 kPa; 95% CI, 4.49 to 4.98), IAD (0.08 mm; 95% CI, 0.11 to 0.27), or IMT
(0.029 mm; 95% CI, 0.002 to 0.060). However, the IMT regression coefficient was half that of DM-2.
Conclusions—DM-2 is associated with preserved LD at increased IMT, which, however, does not normalize the increased
C. In contrast, impaired glucose metabolism is not associated with changes in LD or IAD, whereas IMT is moderately
increased but C remains constant. Carotid remodeling in DM-2 thus appears maladaptive, which may explain the
increased CVD risk, especially stroke, in DM-2. (Stroke. 2004;35:671-676.)
Key Words: arterial remodeling  carotid arteries  diabetes mellitus  epidemiology
Adeteriorating glucose tolerance status is associated withan increased cardiovascular disease (CVD) risk. The
mechanisms responsible for this increased risk remain un-
clear but are likely to involve functional and structural
alterations in large arteries.1,2
The process of arterial remodeling, ie, the change in
structural arterial properties through time in response to
atherogenic and/or hemodynamic alterations within the arte-
rial environment, is thought to be an adaptive phenomenon
aimed at maintaining circumferential wall and shear stresses
within certain limits of operation and possibly at preserving
compliance.3,4 Arterial remodeling is characterized by wall
thickening (indicated by an increase in intima-media thick-
ness (IMT)] and diameter widening [indicated by an increase
in interadventitial diameter [IAD]).5,6 At the biochemical
level, arterial remodeling is characterized by a complex set of
interactions between vasoactive molecules (eg, nitric oxide),
enzymes (eg, matrix metalloproteinases), and inflammatory
cells (monocytes/macrophages).5,7
Three different patterns of arterial remodeling have been
identified: inward (characterized by a decrease in lumen
diameter [LD] resulting from a greater change in IMT than in
IAD), outward (characterized by an increase in LD caused by
a greater change in IAD than in IMT), and compensatory
(characterized by LD preservation despite changes in IMT
and IAD) remodeling.5,6 Recent studies suggested that inward
remodeling and outward remodeling are associated with
distinct forms of plaque formation, ie, inward with stable
plaque formation and outward with unstable plaque forma-
tion.5 As such, inward remodeling and outward remodeling
have been recognized as markers of CVD risk.8 Yet, it is
unclear to what extent the process of remodeling is driven by
atherogenic factors (ie, the presence of atherosclerosis)9,10
compared with hemodynamic factors (ie, increased blood
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pressure).11 This is of particular importance because in-
creased IMT could be the consequence of an unfavorable
atherogenic milieu, subsequently leading to increases in IAD
(ie, the increase in IMT drives the increase in IAD), whereas
alternatively IAD could be the consequence of an unfavorable
hemodynamic milieu, which in turn could lead to increases in
IMT (ie, the increase in IAD drives the increase in IMT).
Alternatively, changes in IMT and IAD may be driven by
different processes and thus be unrelated.
With deteriorating glucose tolerance, both IMT2,12–14 and
IAD2 increase. However, previous studies either have tar-
geted selected populations12–16 and/or did not consider IMT
and IAD in combination and therefore did not address the
issue of remodeling. In view of these considerations, we
examined in a population-based cohort the associations be-
tween glucose tolerance and carotid remodeling. Addition-
ally, we investigated whether any relationship between glu-
cose tolerance and carotid remodeling was mediated through
either the presence of atherosclerosis or increased blood
pressure.
Methods
Study Population
For the present investigation, we used data from the 2000 Hoorn
Study follow-up examination2 and the Hoorn Screening Study.17
Details have been given elsewhere.2,17 The study population con-
sisted of 822 individuals: 290 with normal glucose metabolism
(NGM), 187 with impaired glucose metabolism (IGM), and 345 with
type 2 diabetes (DM-2).
Carotid Artery Properties
Carotid ultrasonography was performed with previously described
techniques.2 A single observer obtained structural properties of the
right common carotid artery with an ultrasound scanner (350 Series
[7.5-MHz linear probe], Pie Medical, the Netherlands). The scanner
was connected to a personal computer equipped with wall track
software (WTS, Pie Medical, the Netherlands) that enables measure-
ment of IAD and IMT.2,18,19
From IAD and IMT, LD was calculated as LDIAD(2 · IMT)
in millimeters. Circumferential wall stress (C) was calculated as
CPP(LD/IMT) in kilopascals, where PP is carotid pulse pressure
(PP) estimated by distension waveform calibration.2,20
Reproducibility
The intraobserver intersession coefficients of variation
[CV(standard deviation of the mean difference divided by the
square root of 2) divided by pooled mean] were 2.9% for IAD,
10.9% for IMT, and 12.3% for C.2
Other Measurements
Health status, medical history, medication use, and smoking habits
were assessed by questionnaire.2,17 We determined systolic and
diastolic pressures; mean arterial pressure (MAP); PP; hypertension;
glucose; glycohemoglobin; insulin; serum total, high- (HDL), and
low-density lipoprotein (LDL) cholesterol; serum triglycerides; body
mass index (BMI); waist-to-hip ratio; and ankle-brachial pressure
index as described elsewhere.2,17,21
Insulin resistance was calculated according to the HOMA mod-
el.22 Prior CVD was defined as described previously.2 We considered
TABLE 1. Characteristics of the Study Population According to Glucose Tolerance
NGM IGM DM-2 P (Trend)
MF, n 278 (135/143) 168 (84/84) 301 (156/145)   
Age, y 696 706 678 0.18
Systolic pressure, mm Hg 13720 14517 14920 0.001
Diastolic pressure, mm Hg 759 789 809 0.001
Hypertension, % 56 73 82 0.001
Antihypertensive medication, % 26 39 51 0.001
Total cholesterol, mmol/L 5.81.0 5.81.0 5.61.1 0.005
HDL cholesterol, mmol/L 1.50.4 1.40.4 1.30.4 0.001
LDL cholesterol, mmol/L 3.70.9 3.70.9 3.50.9 0.003
Triglycerides, mmol/L 1.2 (0.9–1.5) 1.4 (1.0–1.8) 1.7 (1.2–2.3) 0.001
Lipid-lowering medication, % 13 17 19 0.039
Fasting glucose, mmol/L 5.40.4 6.10.5 7.71.8 0.001
Postload glucose, mmol/L 5.61.2 8.01.7 11.72.9 0.001
Insulin,* pmol/L 46.1 (35.2–59.7) 65.4 (48.9–88.2) 84.8 (56.3–116.8) 0.001
Insulin resistance,* AU 1.6 (1.2–2.1) 2.5 (1.9–3.2) 3.6 (2.5–5.4) 0.001
Glycated hemoglobin, % 5.690.41 5.880.39 6.620.93 0.001
BMI, kg/m2 26.23.3 27.94.1 29.35.0 0.001
Height, cm 1699 1709 1709 0.88
Waist-to-hip ratio 0.900.09 0.940.08 0.960.10 0.001
Smoking, % 15 17 14 0.54
Creatinine, mol/L 9514 9515 9520 0.84
(Micro)albuminuria, % 10 15 21 0.001
Prior CVD, % 43 48 56 0.001
AU indicates arbitrary units. Data are reported as meanSD or median (interquartile range).
*n734 because 13 with DM-2 were on insulin therapy.
672 Stroke March 2004
 at Vrije on July 11, 2011http://stroke.ahajournals.org/Downloaded from 
the presence of prior CVD a reflection of the atherogenic milieu and
blood pressure a reflection of the hemodynamic arterial milieu.
Statistical Analysis
All analyses were performed with SPSS (SPSS Inc). We used
analysis of covariance to investigate trends in CVD risk factors and
arterial properties across categories of glucose tolerance. We used
multiple linear regression analyses to investigate the associations
between glucose tolerance and IAD, IMT, LD, and C. All associa-
tions were analyzed first without adjustments and then with adjust-
ments for potential confounders. Because arterial properties are
affected by age, sex, height, and BMI,9,23–26 these variables were
considered first in the adjusted models. After we assessed the main
effects, interactions terms were used to examine whether the asso-
ciation between glucose tolerance and arterial remodeling differed
according to the presence or absence of prior CVD or differed with
blood pressure. Individuals with impaired fasting glucose (n61)
and impaired glucose tolerance (n107) did not differ from each
other with regard to these analyses and were therefore combined.
Values of P0.05 were considered statistically significant, except
for the interaction analyses, where we used P0.10.
Results
Ultrasonography
Of the 822 participants, 18 did not take part in the ultrasound
examination for logistical reasons; in 8, data collection failed
for technical reasons. In the remaining 796 individuals,
qualitatively satisfactory examinations were obtained of 747
carotid arteries. The main reason for missing data was poor
definition of the arterial wall attributable to obesity (BMI of
those with versus those without qualitatively satisfactory
examinations, 26.93.3 versus 31.35.6 kg/m2; P0.001).
Baseline Characteristics
Table 1 shows the characteristics of the study population
according to glucose tolerance. Of the 60 individuals with
previously diagnosed DM-2, 13 were treated with insulin and
47 with blood glucose–lowering medication.
Carotid Artery Properties
Table 2 shows that, with deteriorating glucose tolerance,
IAD, IMT, LD, brachial MAP, carotid PP, and C increased.
Glucose Tolerance and LD
Table 3 shows that, compared with NGM, the association
between DM-2 and LD was not statistically significant after
adjustment for age, sex, height, and BMI (model 2). Addi-
tional adjustment for prior CVD did not change the regression
coefficient (model 3). In contrast, the association between
DM-2 and LD completely disappeared after adjustment for
MAP and/or PP (models 4 through 6). The association
between IGM and LD was not statistically significant (mod-
els 1 through 6). The Figure shows adjusted mean values for
LD, IAD, IMT, and C according to glucose tolerance.
Glucose Tolerance and IAD
Compared with NGM, the association between DM-2 and
IAD remained statistically significant after adjustment for
age, sex, height, BMI, and prior CVD (Table 3, models 2 and
3). After adjustment for MAP and/or PP, the association
between DM-2 and IAD almost completely disappeared
(models 4 through 6). The association between IGM and IAD
TABLE 2. Carotid Artery Properties According to
Glucose Tolerance
NGM IGM DM-2 P (Trend)
IAD, mm 7.801.15 8.041.14 8.090.99 0.001
LD, mm 6.131.06 6.261.04 6.310.92 0.030
IMT, mm 0.830.17 0.880.16 0.880.17 0.001
MAP, mm Hg 9512 10010 10211 0.001
Carotid PP, mm Hg 5917 6214 6716 0.001
c, kPa 6024 6017 6623 0.002
Results are expressed as meanSD.
TABLE 3. Carotid Artery Remodeling According to Glucose Tolerance
Models Added Variables
LD IAD IMT c
IGM DM-2 IGM DM-2 IGM DM-2 IGM DM-2
1 Crude 0.12 0.18 0.24 0.30 0.045 0.051 0.25 6.08
(0.06 to 0.33) (0.02 to 0.35) (0.03 to 0.45) (0.12 to 0.47) (0.012 to 0.077) (0.024 to 0.079) (4.49 to 4.98) (2.23 to 9.94)
2 ModelSexage
heightBMI
0.03 0.13 0.10 0.25 0.027 0.052 0.65 5.77
(0.15 to 0.21) (0.03 to 0.29) (0.09 to 0.28) (0.09 to 0.41) (0.003 to 0.058) (0.026 to 0.079) (5.38 to 4.07) (1.75 to 9.80)
3 Model 2prior CVD 0.008 0.13 0.08 0.24 0.029 0.050 1.39 5.00
(0.17 to 0.19) (0.03 to 0.29) (0.11 to 0.27) (0.07 to 0.41) (0.002 to 0.060) (0.024 to 0.077) (6.14 to 3.29) (0.92 to 9.08)
4 Model 3MAP 0.07 0.00 0.00 0.11 0.026 0.045      
(0.24 to 0.11) (0.16 to 0.16) (0.18 to 0.18) (0.06 to 0.28) (0.005 to 0.057) (0.017 to 0.073)
5 Model 3PP 0.03 0.01 0.00 0.09 0.022 0.040      
(0.22 to 0.16) (0.17 to 0.16) (0.19 to 0.19) (0.08 to 0.26) (0.011 to 0.055) (0.011 to 0.070)
6 Model 3MAPPP 0.07 0.04 0.04 0.06 0.023 0.041      
(0.25 to 0.12) (0.21 to 0.13) (0.23 to 0.15) (0.11 to 0.23) (0.010 to 0.056) (0.011 to 0.070)
7 Model 5IAD             0.021 0.037      
(0.10 to 0.053) (0.009 to 0.065)
Results are expressed as regression coefficients (95% CI).
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was not statistically significant after adjustment (models 2
through 6).
Glucose Tolerance and IMT
Compared with NGM, the association between DM-2 and
IMT remained statistically significant after adjustment for
age, sex, height, BMI, and prior CVD (Table 3, models 2 and
3). After adjustment for MAP and/or PP, the association
decreased but remained statistically significant (models 4
through 6). Compared with NGM, IGM was not significantly
associated with IMT after adjustment for MAP and/or PP
(models 4 through 6), but the regression coefficients were
about half those of DM-2. The association between DM-2
(and IGM) and IMT was driven to a minor extent by parallel
changes in IAD (model 7).
Glucose Tolerance and C
Compared with NGM, the association between DM-2 and C
remained statistically significant after adjustment for age,
sex, height, BMI, and prior CVD (Table 3, models 2 and 3).
The association between IGM and C was not statistically
significant (models 1 through 3).
Impact of Hyperglycemia and/or Insulinemia and
Insulin Resistance on IMT
To estimate the contribution of hyperglycemia and hyperin-
sulinemia or insulin resistance to the increase in IMT asso-
ciated with glucose tolerance, we compared the analyses
(adjusted for sex, age, height, BMI, prior CVD, and carotid
PP) with those additionally adjusted for indexes of hypergly-
cemia (either fasting or postload glucose or HbA1c), hyper-
insulinemia (fasting insulin), or insulin resistance (HOMA).
This showed that the combined contribution of hyperglyce-
mia and/or insulinemia and insulin resistance explained 43%
of the association between glucose tolerance and IMT (data
not shown).
Additional Analyses
Additional adjustment for heart rate, lipid profile, use of
lipid-lowering or antihypertensive medication, smoking, se-
rum creatinine, or (micro)albuminuria did not materially alter
the results. If we replaced BMI with waist-to-hip ratio, the
results were also not materially altered (data not shown).
No significant interaction terms were observed between
glucose tolerance and prior CVD or between glucose toler-
ance and blood pressure (data not shown).
If we plotted IMT against LD to explore whether LD
decreased at high IMT,9,25 no such phenomenon was ob-
served (data not shown).
Discussion
The present investigation, the first population-based study on
the association between glucose tolerance status and carotid
arterial remodeling, had 3 main findings. First, DM-2 is
associated with a pattern of compensatory remodeling (ie,
preservation of LD at increased IMT), which, however, does
not normalize C, which increased. IGM was not associated
with a particular pattern of remodeling. Second, in DM-2, the
increase in IAD but not IMT was explained by blood
pressure. Prior CVD did not explain the increase in IAD nor
the increase in IMT. Third, DM-2 and (less so) IGM were
associated with an increase in IMT, and 43% of the associ-
ation between glucose tolerance and IMT was explained by
hyperglycemia and/or insulinemia and insulin resistance.
Taken together, our results show that DM-2 is associated with
compensatory remodeling, whereas IGM is not associated
with a particular pattern of remodeling. In DM-2, the alter-
ations in IMT and IAD are unrelated and differentially
driven: The increase in IMT is driven mainly by deteriorating
glucose tolerance, whereas that in IAD is driven by increased
blood pressure.
Our findings support the hypothesis that blood pressure,
particularly its pulsatile component, exerts a fatiguing effect
on the load-bearing elements of the arterial wall (ie, elastin
and collagen), resulting in degenerative changes and fractures
and IAD enlargement.11 A methodological advantage of our
study was the fact that we were able to quantify local carotid
PP.2 This is important because of PP amplification,27 which
could distort the association between pressure and arterial
Adjusted mean values for LD, IAD, IMT,
and C according to glucose tolerance.
C was adjusted for sex, age, height,
BMI, and prior CVD. LD, IAD, and IMT
were also adjusted for PP. *P0.05.
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geometry if brachial PP is used as an estimate of carotid PP.
We also show that the increase in IMT was largely indepen-
dent of blood pressure and was driven only to a minor extent
by the increase in IAD. Therefore, deteriorating glucose
tolerance is an independent determinant of increased IMT.
This latter finding is supported by the observation that IMT
increased before the onset of DM-2 and by the observation
that 43% of the relationship between glucose tolerance and
IMT could be explained by the combination of hyperglyce-
mia and/or insulinemia and insulin resistance, which may be
markers of increased carbonyl and oxidative stress, including
the effect of Amadori adducts and advanced glycation end
products.28
The relationship between IMT and LD is complex. Previ-
ous population-based studies on age-related carotid remodel-
ing9,23–26 have not provided consistent results; they have
observed LD to increase with increasing IMT,24,26 LD to
remain constant with increasing IMT,23 and LD to increase
with increasing IMT only up to a certain level of IMT, after
which LD markedly decreased.9,25 Here, we described glu-
cose tolerance–related carotid remodeling and observed that
LD remained constant with increasing IMT. Importantly, our
data suggest that, with deteriorating glucose tolerance,
changes in IAD and IMT are driven by hemodynamic and
metabolic factors, respectively, which may explain why the
changes in LD and IMT appear to be uncoordinated.
In apparent contrast to the present results, we have previ-
ously observed that the increase in IAD during a 3-year
follow-up of individuals with impaired glucose tolerance
appeared partly attributable to hyperglycemia.29 However, we
may have underestimated the role of PP in our previous
investigation29 because there was selective mortality of indi-
viduals with high PP,30 which may have caused a relative
increase in the importance of the role of hyperglycemia.
Our study had several limitations. First, ultrasound cannot
discriminate between the intimal and medial layers of the
artery, and this would have given more insight into changes
thought the be particularly associated with atherosis (intima)
or arteriosclerosis (media).5 This limitation will most cer-
tainly be eliminated in future studies by the rapid develop-
ment of ultrasound image processing.31 Second, we used a
single-point measurement technique32,33 to determine IMT.
Therefore, our results may have been influenced by variabil-
ity of IMT along the arterial segment.19 However, we mini-
mized measurement variability by clearly defining where
IMT was determined.2 Third, our results were obtained in a
white, relatively healthy, elderly population; thus, inferences
should be made with care.
In conclusion, DM-2 is associated with preservation of
carotid LD at increased IMT (ie, compensatory remodeling),
which, however, does not normalize C, which remains
increased. In contrast, IGM is not associated with changes in
LD or IAD. IMT is moderately increased, but C remains
normal. Carotid remodeling in DM-2 thus appears maladap-
tive, which may explain the increased risk of CVD, especially
stroke, in DM-2.
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